FDA approves Kura and Kyowa Kirin’s drug for form of acute myeloid leukemianews2025-11-13T19:58:31+00:00November 13th, 2025|Endpoints News|
Law to end government shutdown also seeks to accelerate prescription-to-OTC switchesnews2025-11-13T19:35:40+00:00November 13th, 2025|Endpoints News|
UK gives drugmakers third extension to opt out of medicine rebate schemenews2025-11-13T18:39:59+00:00November 13th, 2025|Endpoints News|
Pfizer closes up to $10B deal for obesity biotech Metseranews2025-11-13T17:51:38+00:00November 13th, 2025|Endpoints News|
Hims launches lab testing for preventive carenews2025-11-13T17:00:04+00:00November 13th, 2025|Endpoints News|
AbbVie, Alphabet’s Calico end 11-year partnership in aging researchnews2025-11-13T16:09:58+00:00November 13th, 2025|Endpoints News|
MacroGenics stops work on a bispecific; Third Arc Bio makes a deal with Adagenenews2025-11-13T15:56:22+00:00November 13th, 2025|Endpoints News|
Day One to buy struggling ADC maker Mersana for $129Mnews2025-11-13T15:54:28+00:00November 13th, 2025|Endpoints News|
Abeona’s skin disease cell therapy launch stymied by false-positive sterility testnews2025-11-13T15:43:19+00:00November 13th, 2025|Endpoints News|
